Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108033922A reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with green chemistry.
Patent CN104193667A reveals a novel metal-catalyzed route for azacycles. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN115260080B reveals efficient one-step carbonylation. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Novel palladium-catalyzed carbonylation route offers high purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability.
Patent CN112341468A reveals a novel copper-catalyzed route to azetidino-1,4-benzodiazepines, offering high yields and streamlined functionalization for API manufacturing.
Novel metal-free method for trifluoroacetimide-substituted dihydrobenzofuran. Enhances purity and supply chain stability for pharmaceutical intermediates globally.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN113045489B details a novel Pd-catalyzed route for quinolin-2(1H)ones, offering cost-effective API intermediate manufacturing with high functional group tolerance.
Novel patent CN114195711B offers efficient quinoline-4(1H)-one synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates.
Patent CN112480015B reveals an efficient Pd-catalyzed route for high-purity quinazolinone intermediates, offering significant cost and supply chain advantages.
Patent CN112125856A reveals a safe Pd-catalyzed carbonylation route for quinazolinone derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN102040564B reveals a safe, high-yield nucleophilic substitution route for 3-aminobenzo[d]isothiazole, offering significant cost reduction and supply chain stability for pharma manufacturing.
Patent CN113801050A reveals a copper-catalyzed method for highly functionalized beta-lactams, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Patent CN109134351B details a novel synthesis of S-3-(4-aminophenyl)piperidine with >99% ee, offering cost-effective scalability for PARP inhibitor manufacturing.
Novel Pd-catalyzed synthesis offers high efficiency and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN112125856A reveals a safe Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN114195711B reveals efficient Pd-catalyzed carbonylation. Offers cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain.
Novel Pd-catalyzed carbonylation method for indole and benzoxazine compounds offering significant cost reduction and enhanced supply chain reliability for global pharmaceutical intermediates.
Novel 5-step synthesis of Trilaciclib via CN114014864A. Offers high purity, mild conditions, and cost-effective manufacturing for global pharmaceutical supply chains.
Novel Pd-catalyzed synthesis offers cost reduction in pharmaceutical intermediate manufacturing with high purity and scalable supply chain reliability for global buyers.